FIELD: medicine.
SUBSTANCE: group of inventions relates to a method of treating a condition selected from a group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome, in a mammal, including a human, involving administering to a mammal subject in need thereof, a therapeutically effective amount of a pharmaceutical composition comprising: (a) compound 14-3: or a pharmaceutically acceptable salt thereof, which is effective for treating or preventing a condition selected from a group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome, mammal, including human, and (b) the pharmaceutically acceptable excipient, carrier or diluent also relates to a method of treating a condition associated with increased intracellular accumulation of triglycerides in liver cells of a mammal, including a human, where said condition is selected from the group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome, wherein said method involves administering to a mammal subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising: compound selected from a group consisting of: and or a pharmaceutically acceptable salt thereof; and (b) a pharmaceutically acceptable excipient, carrier or diluent.
EFFECT: group of inventions provides treating a condition selected from a group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome in a mammal.
7 cl, 34 dwg, 10 ex
Title |
Year |
Author |
Number |
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE |
2019 |
- Li, Chian Dzh.
- Derdak, Zoltan
- Lyu, Tszifen
|
RU2815647C2 |
NOVEL IMMUNE SYSTEM MODULATORS RELATED APPLICATIONS |
2012 |
- Lipford Grejson B.
- Zepp Charlz M.
|
RU2606114C2 |
IMIDAZOQUINOLINE SUBSTITUTED PHOSPHORIC ACID ESTER AS AGONIST, ITS PREPARATION AND USE |
2020 |
- Lv, Binhua
- Cui, Dawei
- Chai, Chuanke
- Liu, Ruifeng
- Sheng, Zelin
|
RU2812182C1 |
MACROCYCLIC SERINE PROTEASE INHIBITORS |
2009 |
- Parsi Kristof Klod
- Aleksandr Fransua-Rene
- Sjurlero Dominik
- Derok Mishel'
- Lerua Frederik
|
RU2490272C2 |
NOVEL CYCLOSPORIN DERIVATIVES FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS |
2011 |
- Su Chzhuan
- Long Chzhenjuj
- Khuan Chzhennjan
- Jan Sujchzhou
|
RU2601742C2 |
5,5-CONDENSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS |
2010 |
- Dusson Siril B.
- Djukan David
- Parsi Kristof Klod
- P'Erra Kler
- Aleksandr Fransua-Rene
- Brand Gijom
- Da Kosta Daniel'
- Raali Usin
- Paparehn Zhan-Loran
- Derok Mishel'
- Konvar T'Erri
- Sjurlero Dominik
|
RU2554087C2 |
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TREATING CANCER |
2015 |
|
RU2741914C2 |
HETEROCYCLIC AMIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION AND USE THEREOF |
2020 |
- Duan, Wenhu
- Geng, Meiyu
- Zhang, Huibin
- Xie, Zuoquan
- Zhou, Jinpei
- Yang, Yifei
- Wang, Xiyuan
- Yang, Xiaojun
- Zhang, Yan
- Hu, Zhaoxue
- Ding, Jian
|
RU2823875C1 |
(ALPHA-SUBSTITUTED ARALKYLAMINO- AND HETEROARYLALKYLAMINO)PYRIMIDINYL- AND 1,3,5-TRIAZINYLBENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF IN TREATING PROLIFERATIVE DISEASES |
2012 |
- Braun S. Devid
- Mettyuz Devid Dzh.
|
RU2608742C2 |
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER |
2018 |
- Li, Dansu
- Snir-Alkalaj, Irit
- Vakka, Jozef
- Ben Neriakh, Jinon
- Venkatak-Ialam, Avantika
|
RU2761457C2 |